Fundraising FoxGenoa Ventures — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
BrightSpec develops molecular rotational resonance (MRR) spectroscopy instruments and software that identify and quantify gas-phase molecules from complex mixtures without front-end separation.
BiotechDeep TechHardwareWaltham, US
Rick Gordon(CEO)inWalter Colsman(Executive Officer, Director)JAFFRAY WOODRIFF(Director)ROBERT LLOYD(Executive Officer, Director)THOMAS JONES(Director)DAVID MCDANIEL(Executive Officer, Director)
Board seatJenny Rooke· per SEC Form D
Co-investorsArboretum VenturesMedvest Capital
Extracellular is a biomanufacturing company that helps cell-based product developers in cultivated meat, plant cell culture, and bioactives accelerate discovery, overcome production challenges, and commercialize their products.
Advanced ManufacturingBiotechFoodTechNew Materials
Will Milligan(CEO & Founder)in
Co-investorsBig Idea VenturesFFFNewland SyndicateUnruly Capital5AM VenturesAgent Capital+8 more
Hermes Biosciences develops a benchtop extracellular vesicle isolation system that purifies exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.
BiotechDeep TechMedical Devices
Co-investorsGENERAL INCEPTIONPaladin Capital Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.